Don't want ads? Subscribe or login now.

Amgen To Pay $780M To Settle Drug Sales Suits

By Keith Goldberg · October 24, 2011, 10:50 PM EDT

Amgen Inc. said Monday it would pay $780 million to settle allegations over its sales and marketing practices stemming from civil and criminal investigations — including Medicaid claims and a whistleblower...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Statement

Case Information

Case Title

United States of America et al v. Amgen Inc.

Case Number

1:06-cv-10972

Court

Massachusetts

Nature of Suit

Other Statutory Actions

Date Filed

June 05, 2006

Recent Articles By Keith

January 12, 2024
Tax Bonus Rules Create A Clean Energy Contracting Crunch
January 02, 2023
5 Inflation Reduction Act Questions For The Energy Industry
July 07, 2020
PPP Life Raft Will Soon Deflate For Oil Field Service Cos.
January 17, 2020
DC Circ. Says Arch Coal Can't Duck Benefit Payments
October 03, 2019
Valero Refinery Worker Burned In 'Superheated Soil' Can't Sue
August 16, 2019
NLRB Can't Levy Violation Against Marathon, 6th Circ. Says
August 14, 2019
Oil Slump, Not Age, Cost Transocean Worker His Job: 5th Circ.
February 27, 2019
8th Circ. Won't Revive Contractor's Suit Against Drilling Co.
January 11, 2019
High Court Will Take Up Calif. Offshore Drilling Wage Dispute
May 11, 2018
Oil Firm's Rival Didn't Steal Trade Secrets, Judge Rules